An economic study reveals wide-ranging costs in bringing new drugs to market, with pharmaceutical companies experiencing stable research and development (R&D) intensity, suggesting potential for reduced prices without compromising innovation.
New study findings reveal a significant proportion of first-episode psychosis diagnoses in patients aged 35 or older, with potential sex-specific vulnerabilities and diverse support needs highlighted.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
The landmark Supreme Court decision on federal agencies' authority is expected to bring significant changes to the healthcare system, including increased litigation, potential disparity in regulations, and heightened uncertainty for patients and providers.